Dexcom grabs CE mark for CGM with no finger stick; Medtronic gets another MRI-compatible approval;

@FierceMedDev: ICYMI Friday: Startup Velico nabs another $15.5M from BARDA for dried plasma tech. Story | Follow @FierceMedDev

@EmilyWFierce: A little background on the FDA's regulation of drug marketing. More from The Atlantic | Follow @EmilyWFierce

> Medtronic ($MDT) got FDA approval for its Evera SureScan implantable cardioverter defibrillator (ICD) system for use with magnetic resonance imaging (MRI) scans. More

> Dexcom ($DXCM) nabbed a CE mark for its G5 continuous glucose monitoring system that doesn't require confirmatory finger sticks for adults and children as young as two. The device got FDA approval a few weeks ago--but that still included the need for finger sticks. More

> Philips ($PHG) will install its technology in a new cardiovascular center at Catharina Hospital in the Netherlands. It's slated to open in mid-2016. More

Biotech News

@FierceBiotech: ICYMI: FierceBiotech Radio on GSK's latest setback, Kyle Bass' 'truthful irrelevancy,' and Horizon's web presence. More | Follow @FierceBiotech

@JohnCFierce: ICYMI: UPDATED: Melinta's CEO steps down amid a big Phase III push. Article | Follow @JohnCFierce

> Raptor's NASH gamble blows up in Phase II pediatric trial. News

> Gene therapy player Dimension catches the biotech IPO wave, files $115M offering. More

> Acacia looks to a $230M IPO in London as it steers through PhIII. Article

Pharma News

@FiercePharma: ICYMI: Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains. Article | Follow @FiercePharma

@EricPFierce: ICYMI: Sun targets Ranbaxy plant in Ireland as it prepares to trim manufacturing network. More | Follow @EricPFierce

@CarlyHFierce: ICYMI: Boehringer's Ofev, chasing a Roche rival, wins backing from NICE. Story | Follow @CarlyHFierce

> Shire casts about for creative ways to woo Baxalta shareholders. Story

> Advera Health Analytics: Merck statins linked to more muscle side effects than rest of class. Article

Animal Health News

> Phibro doubles earnings as demand for specialty animal products skyrockets. More

> Regulatory challenges top of mind at inaugural ACI animal health forum. Report

> FDA issues groundbreaking rules for manufacturing safe pet foods. Story

> McDonald's commits to cage-free eggs. Item

> USDA, poultry producers warn MN officials to expect bird flu resurgence. Article

Biotech IT News

> IBM inks deals to give Watson a role in R&D at Icon and Teva. News

> GSK picks Siemens as preferred supplier of automation tech. Report

> HudsonAlpha pairs HiSeq X Ten with Dragen processor to boost throughput. More

> Adaptimmune poaches GSK vet to lead biometrics team. Story

> AstraZeneca commits $18M to clinical trial bioinformatics collaboration. Article

Pharma Marketing News

> Surprise: J&J moves $1B U.S. media buying account back to Interpublic. Article

> Sanofi's combo med LixiLan ready to go to FDA in ongoing scramble for diabetes dominance. Report

> Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana. Story

> AstraZeneca's lauded 'Take it From a Fish' campaign scores again at Clio Healthcare awards. More

> AZ's high-powered Crestor could gain from payer limits on PCSK9 meds. Article